HR 4438
118th Congress
House
Health
Cardiovascular and respiratory health
Genetics
Health care coverage and access
Health personnel
Hereditary and development disorders
Home and outpatient care
Medicare
John W. Walsh Alpha-1 Home Infusion Act of 2023
Introduced: June 30, 2023
Introduced by:
Salazar, Maria Elvira
Republican
· Florida
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Referred to the Subcommittee on Health.
Jul 7, 2023
Referred to the Subcommittee on Health.
Jun 30, 2023
Introduced in House
Jun 30, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Plain-English summary
John W. Walsh Alpha-1 Home Infusion Act of 2023
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4